Evidence map›Paper›PMID 36414627›Full record

ArticleNature communications2022

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.

Joyce V Lee, Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M Anttila, Pauliina M Munne, Mariel Savelius, Kathleen E Houlahan, Daniel Van de Mark and 13 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 5 countries.

Joyce V Lee *Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Filomena Housley *Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Christina YauCancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA.
Rachel NakagawaDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Juliane WinklerDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-9762-1721
Johanna M AnttilaFinnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1333-2069
Pauliina M MunneFinnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-9720-9964
Mariel SaveliusFinnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.
Kathleen E HoulahanStanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Daniel Van de MarkDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Golzar HemmatiDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Grace A HernandezDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Yibing ZhangDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Susan SamsonHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Carole BaasAlamo Breast Cancer Foundation, San Antonio, Texas, USA.
Marleen KokDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Laura J EssermanHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.ORCID http://orcid.org/0000-0001-9202-4568
Laura J van 't VeerHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-9838-8298
Hope S RugoHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.ORCID http://orcid.org/0000-0001-6710-4814
Christina CurtisStanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Juha KlefströmFinnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-7124-8431
Mehrdad MatloubianDepartment of Medicine, Division of Rheumatology and Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of California, San Francisco, California, USA. mehrdad.matloubian@ucsf.edu.
Andrei GogaDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.ORCID http://orcid.org/0000-0001-9127-0986
University of California, San Francisco · USUniversity of Helsinki · FIStanford University · USBuck Institute for Research on Aging · USEast Foundation · USThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36414627
PMCPMC9681724
OpenAlexW4309651073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.